Literature DB >> 21146714

Direct detection of isoniazid-resistant Mycobacterium tuberculosis in respiratory specimens by multiplex allele-specific polymerase chain reaction.

Gilman Kit Hang Siu1, Yuk Ho Tam, Pak Leung Ho, Ann Siew Gek Lee, Tak Lun Que, Cindy Wing Sze Tse, Kam Tong Yip, Jason Tsz Hin Lam, Vincent Chi Chung Cheng, Kwok Yung Yuen, Wing Cheong Yam.   

Abstract

This study evaluated the feasibility of using 2 multiplex allele-specific polymerase chain reaction (MAS-PCR) assays targeting 2 mutations (codon 315 of the katG gene and the 15th nucleotide preceding the mabA-inhA operon) to directly detect isoniazid (INH)-resistant Mycobacterium tuberculosis in cultured isolates and respiratory specimens. A total of 203 M. tuberculosis isolates and 487 respiratory specimens were investigated. The MAS-PCR assays successfully amplified all M. tuberculosis isolates and acid-fast bacilli smear-positive specimens while only 49.2% of the smear-negative specimens exhibited positive MAS-PCR results. The MAS-PCR assays identified 83.4% and 79.2% of the resistant strains in the culture isolates and respiratory specimens, respectively. All the inferred genotypes were in complete accordance with subsequent DNA sequence analyses. This study suggested the application of our improved MAS-PCR protocols to provide the rapid identification of INH-resistant M. tuberculosis directly in respiratory specimens. The technical simplicity, short turnaround time, and low cost of this molecular strategy should facilitate routine diagnostic services in developing areas with a high prevalence of drug-resistant tuberculosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21146714     DOI: 10.1016/j.diagmicrobio.2010.08.021

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  An upstream truncation of the furA-katG operon confers high-level isoniazid resistance in a Mycobacterium tuberculosis clinical isolate with no known resistance-associated mutations.

Authors:  Gilman Kit Hang Siu; Wing Cheong Yam; Ying Zhang; Richard Y T Kao
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

2.  Clinical utility of target amplicon sequencing test for rapid diagnosis of drug-resistant Mycobacterium tuberculosis from respiratory specimens.

Authors:  Kenneth Siu-Sing Leung; Kingsley King-Gee Tam; Timothy Ting-Leung Ng; Hiu-Yin Lao; Raymond Chiu-Man Shek; Oliver Chiu Kit Ma; Shi-Hui Yu; Jing-Xian Chen; Qi Han; Gilman Kit-Hang Siu; Wing-Cheong Yam
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064

3.  Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.

Authors:  Flávia A D de Freitas; Vagner Bernardo; Michel K Gomgnimbou; Christophe Sola; Hélio R Siqueira; Márcia A S Pereira; Fátima C O Fandinho; Harrison M Gomes; Marcelo E I Araújo; Philip N Suffys; Elizabeth A Marques; Rodolpho M Albano
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

4.  Comparative Whole-Genomic Analysis of an Ancient L2 Lineage Mycobacterium tuberculosis Reveals a Novel Phylogenetic Clade and Common Genetic Determinants of Hypervirulent Strains.

Authors:  Rahim Rajwani; Wing Cheong Yam; Ying Zhang; Yu Kang; Barry Kin Chung Wong; Kenneth Siu Sing Leung; Kingsley King Gee Tam; Ketema Tafess Tulu; Li Zhu; Gilman Kit Hang Siu
Journal:  Front Cell Infect Microbiol       Date:  2018-01-12       Impact factor: 5.293

5.  Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil.

Authors:  Thales Alves Campelo; Luana Nepomuceno Costa Lima; Karla Valéria Batista Lima; Caroliny Soares Silva; Marília Lima da Conceição; José Antonio Pereira Barreto; Aquiles Paulino Peres Mota; Soraya de Oliveira Sancho; Cristiane Cunha Frota
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-02-07       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.